Somatus · 3 months ago
VP, Corporate Development
Somatus is the largest and leading value-based kidney care company, empowering patients with chronic kidney disease. The Vice President, Corporate Development will be responsible for leading growth partnerships, mergers, and acquisitions, collaborating with the Executive Team to develop strategies and execute transactions.
Health CareHealth DiagnosticsHospitalMedicalPrimary and Urgent CareWellness
Responsibilities
The Vice President, Corporate Development will work with the Company’s Executive Team and other senior leaders to execute on the Company’s evolving growth partnership, mergers, and acquisitions strategy
Collaborate with the CFO and Executive Team to develop investments and acquisitions strategies
Develop board and investor materials supporting transaction thesis and financials
Financial modeling
Build out relevant acquisition pipelines and prioritization of potential targets
Lead due diligence activities and process
Lead/support deal negotiations and transaction documents
Work cross-functionally to prepare and the organization to execute acquisition integration activities
Qualification
Required
Bachelor's degree
5-7 years of corporate development experience or investment banking experience
Minimum 3 years in Audit (Big 4) / Consulting, M&A (industry or boutique), Investment Banking or Private Equity; preferably experience in executing M&A strategy within a growth organization
Proven ability to drive deal execution from start to finish, including identifying what risks require additional evaluation or mitigation, and when to walk away from a deal
Preferred
Master's degree in Business Administration, Finance, or Engineering
Benefits
Subsidized, personal healthcare coverage (medical, dental vision)
Flexible Paid Time Off (PTO)
Professional Development, CEU, and Tuition Reimbursement
Curated Wellness Benefits supporting teammates physical and mental well-being
Community engagement opportunities
And more!
Company
Somatus
Somatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups.
Funding
Current Stage
Late StageTotal Funding
$465.12MKey Investors
Wellington ManagementFlare Capital Partners
2022-02-22Series E· $325M
2021-06-16Series D· $60.12M
2020-06-23Series C· $64M
Recent News
Company data provided by crunchbase